期刊文献+

血清脂蛋白(a)在高血压肾病诊断中的意义 被引量:5

Serum Lipoprotein-a in the Diagnosis of Hypertensive Nephropathy
下载PDF
导出
摘要 目的:对高血压肾病患者诊断过程中检测血清脂蛋白(a)的意义进行探讨。方法:按照有无肾病,将224例患者分为3组:1组76例,高血压无肾病,2组76例,高血压肾病微量蛋白尿,3组72例,高血压肾病大量蛋白尿。采用免疫比浊法,对患者血清脂蛋白(a)测定,比较血清脂蛋白-a的规律。结果:和高血压无肾病患者对比,高血压肾病微量蛋白尿患者和高血压肾病大量蛋白尿患者血清脂蛋白(a)升高明显,差异有统计学意义(P<0.05)。结论:血清脂蛋白(a)量和尿蛋白的量正相关,这显示血清脂蛋白(a)的含量对高血压肾病的诊断具有重要意义。 Objective:The diagnostic process in patients with hypertensive nephropathy serum lipoprotein-a in the sense discussed. Methods:According to whether the kidney will be 224 cases were divided into 3 groups:The first group of 76 patients with hypertension without kidney disease,the second group of 76 patients,hypertensive nephropathy microalbuminuria,the third group of 72 patients,hypertensive nephropathy pee a lot Protein.By immunoturbidimetric assay for determination of serum lipoprotein-a,comparison of serum lipoprotein-a rule. Results:Comparison of patients without nephropathy and high blood pressure,hypertension,microalbuminuria in patients with kidney disease and hypertension in patients with kidney disease a lot of protein in urine increased significantly in serum lipoprotein-a,the difference was statistically significant (P〈0.05).Conclusion:Serum lipoprotein-a volume and the amount of urinary protein positive correlation, indicating that the content of serum lipoprotein-a diagnosis of hypertensive nephropathy is important.
作者 陈颖 冯洋
出处 《中国医药导刊》 2011年第3期479-480,共2页 Chinese Journal of Medicinal Guide
关键词 高血压肾病 血清脂蛋白(a) 诊断 Hypertension Nephropathy Serum Lipoprotein-a Diagnosis
  • 相关文献

参考文献2

二级参考文献1

共引文献12

同被引文献52

  • 1黎磊石,刘志红.原发性高血压的肾损害[J].肾脏病与透析肾移植杂志,2004,13(4):336-337. 被引量:50
  • 2成威,周胜华,张铭,李旭平.阿托伐他汀对高血压肾病蛋白尿及C-反应蛋白和白介素-6的影响[J].高血压杂志,2005,13(12):767-770. 被引量:43
  • 3桂定坤,顾勇,彭艾,朱秋毓,丁峰,林善锬.黄芪水提物对健康人尿钠排泄的影响及机制研究[J].中华肾脏病杂志,2007,23(4):214-218. 被引量:12
  • 4陈灏珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2009:919.
  • 5Hu B, Gadegbeku C, Lipkowitz MS, et al. Kidney function can improve in patients with? hypertensive? CKD. J Am Soc Nephrol, 2012,23 (4) :706-713.
  • 6Malyszko J, Koc-Zorawska E, Malyszko JS, et al. Kidney injury molecule-1 correlates with kidney function in renal allograft recipients. Transplant Proc ,2010,42( 10 ) :3957-3969.
  • 7Wright JT Jr,Bakris G,Greene T. Effect of blood pressttre lowerillg and antihypertensive durg class on progression of hypertelasive kid- ney disease: results from the AASK trial [ J ]. JAMA, 2002,288 (19) :2421 - 2431.
  • 8Brenner BM, Cooper ME,de Zeeuw D. The losartan renal protection- study-rationale, study design and baseline characteristics of RENAAL ( Reduction of endlmints in NIDDM with the angiotensin Ⅱ antago- nist losartan) [ J ]. JRAAS,2000,1 (4) :328 - 335.
  • 9Mahfoud F,Ukena C,Poss J,et al. Mieroalbuminuria independently correlates to cardiovascular comorbidity burden in patients with hy- pertension[J]. Clin Res Cardiol,2012,27(9) :606 -613.
  • 10Yang J W,Hutchinson I V,Shah T,et al.Gene polymorphism of vascular endothelial growth factor-1154G>A is associated with hypertensive nephropathy in a Hispanic population[J].Molecular biology reports,2011,38(4):2417-2425.

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部